Hilton (HLT) officer exercises options and disposes of 11,905 shares
Rhea-AI Filing Summary
Christopher W. Silcock, President, Global Brands & Commercial Services at Hilton Worldwide Holdings Inc. (HLT), reported option exercise and concurrent sale transactions on 08/21/2025. He exercised 11,905 employee stock options with an exercise price of $41.41 per share, resulting in the acquisition of 11,905 common shares. The same number of shares were sold the same day at a weighted average price of $269.40 (sales ranged $269.37–$269.58). Following these transactions, the reporting person beneficially owned 79,451 shares, down from 91,356 immediately after the acquisition and sale events recorded on the form.
Positive
- Exercise and sale fully disclosed with weighted average sale price and price range provided
- Options exercised at $41.41, a clearly stated exercise price
- Post-transaction beneficial ownership reported (79,451 shares)
Negative
- Reduction in beneficial holdings from 91,356 to 79,451 shares following the transactions
Insights
TL;DR: Routine option exercise and sale by an officer, results in reduced insider holdings but realized proceeds given sale price range.
The filing documents a same-day exercise of 11,905 employee stock options at $41.41 and the sale of 11,905 common shares at a weighted average of $269.40. This is consistent with standard option-exercise liquidity actions by executives. The report shows post-transaction beneficial ownership of 79,451 shares. No additional grants, loans, or unusual derivative positions are reported.
TL;DR: Disclosure is standard Section 16 reporting; transactions appear executed under typical compensation arrangements.
The Form 4 indicates the option vested in installments beginning February 15, 2017, and the reporting person provides the required sales price range disclosure. The signature by an attorney-in-fact is included. There are no indications in the filing of policy exceptions, Rule 10b5-1 reliance checkboxes, or related-party transfers; the filing is a routine disclosure of officer activity.
FAQ
What insider transactions did Christopher W. Silcock report for HLT?
At what price were the HLT shares sold by the reporting person?
How many HLT shares does Christopher W. Silcock beneficially own after the transactions?
What was the exercise price and vesting note for the options exercised?
Was the Form 4 filed individually or jointly for HLT?